Aims The benefit of prolonged implantable cardioverter-defibrillator (ICD)/cardiac
resynchronization therapy defibrillator (CRT-D) therapy following device replacement is …

Aims Patients have increasing comorbidities and competing causes of death with advancing
age, raising questions about the effectiveness of the implantable cardioverter defibrillators …

Objectives This study sought to describe trends in cardiovascular implantable electronic
device (CIED) insertion over the past 3 decades in Olmsted County. Background Trends in …

Aims Cardiac resynchronization therapy (CRT) with a defibrillator (CRT-D) has downsides of
high cost and inappropriate shocks compared to CRT without a defibrillator (CRT-P). Recent …

Introduction With the recent publication of the negative DANISH trial, the mortality benefit of
the implantable cardioverter-defibrillator (ICD) has been put in question in patients with non …

BACKGROUND: Automated implantable cardioverter-defibrillators (ICDs) have become
standard therapy for patients at high risk for sudden cardiac death. Linked data allow …

Aims The purpose of this study was to evaluate whether there are differences in use and
outcome of implantable cardioverter defibrillator (ICD) therapy with or without cardiac …

Implantable cardioverter‐defibrillators (ICDs) reduce mortality in selected high‐risk
populations by reducing the risk of sudden death. No clinical trial examining ICD efficacy …

Background: There are no upper age restrictions for implantable defibrillators (ICDs) but
their benefit may be limited in patients≥ 80 years with strong competing risks of early …

Importance Cardiac resynchronization therapy (CRT) reduces the risk for mortality and heart
failure–related events in select patients. Little is known about the use of CRT in combination …